Argyle Capital Management Inc. Merck & Co., Inc. Transaction History
Argyle Capital Management Inc.
- $248 Million
- Q3 2024
A detailed history of Argyle Capital Management Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Argyle Capital Management Inc. holds 53,648 shares of MRK stock, worth $5.28 Million. This represents 2.46% of its overall portfolio holdings.
Number of Shares
53,648
Previous 56,723
5.42%
Holding current value
$5.28 Million
Previous $7.02 Million
13.24%
% of portfolio
2.46%
Previous 2.92%
Shares
27 transactions
Others Institutions Holding MRK
# of Institutions
3,827Shares Held
1.87BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.6 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.7 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.46 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.82 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $249B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...